Rare and Undiagnosed Diseases Platform – RUDiP

The Rare and Undiagnosed Diseases Platform (IBG-RUDiP) was established within the IBG, in line with the mission of the RareBoost project, to drive innovation and research excellence in the field of rare and undiagnosed diseases through a multidisciplinary approach.

RUDiP consists of 22 faculty members and research groups with expertise in different areas of basic, translational, technological and industrial research related to rare and undiagnosed diseases.

Within RUDiP, rare diseases will be studied from different perspectives using the most advanced research techniques. This collaborative effort aims to advance our knowledge of rare diseases and lead to innovative diagnostic methods and treatment options for affected individuals.

RUDiP laboratories specialize in a wide variety of fields, including human genetics, epigenetics, cancer biology, immunology, computational biophysics, molecular biology, bioinformatics, zebrafish models, gene targeting and biobanking.